Top compounds associated with response to TMEM170A


Feature Type Standardized
Nominal ANOVA
mRNA tandutinib CTRPv2 pan-cancer AAC 0.0083 0.8
mRNA PIK-93 CTRPv2 pan-cancer AAC -0.0079 0.8
mRNA Erlotinib CTRPv2 pan-cancer AAC 0.0076 0.8
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0076 0.8
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.0076 0.8
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.0078 0.8
mRNA Tamoxifen CTRPv2 pan-cancer AAC -0.008 0.8
mRNA BRD-K44224150 CTRPv2 pan-cancer AAC -0.015 0.8
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.0073 0.8
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.0069 0.8
Download CSV